Issue 38 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

36

No.

38

October 22, 2010Oct 22, 2010

DOWNLOAD THE PDF

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

NCI Sends A Second Letter To Groups About Carboplatin

Agency Asks GnRH Sponsors To Add Warnings On Labels

NCI Awards STRAP Grant Of $2 Million To MSKCC

Beth Israel Suspends Enrollment In Trials Following An Audit

NCCN Guidelines Retain Avastin For Breast Cancer

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

Recent Issues

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026